4-((4-fluoro-2-isopropoxyphenyl)amino)-5-methyl-N-(3-(pyrrolidin-1-yl)propyl)thieno[2,3-d]pyrimidine-6-carboxamide

ID: ALA4456938

Chembl Id: CHEMBL4456938

PubChem CID: 131964064

Max Phase: Preclinical

Molecular Formula: C24H30FN5O2S

Molecular Weight: 471.60

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1c(C(=O)NCCCN2CCCC2)sc2ncnc(Nc3ccc(F)cc3OC(C)C)c12

Standard InChI:  InChI=1S/C24H30FN5O2S/c1-15(2)32-19-13-17(25)7-8-18(19)29-22-20-16(3)21(33-24(20)28-14-27-22)23(31)26-9-6-12-30-10-4-5-11-30/h7-8,13-15H,4-6,9-12H2,1-3H3,(H,26,31)(H,27,28,29)

Standard InChI Key:  SYUYQRZJGOEERQ-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4456938

    ---

Associated Targets(Human)

MKNK1 Tchem MAP kinase-interacting serine/threonine-protein kinase MNK1 (2071 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MKNK2 Tchem MAP kinase signal-integrating kinase 2 (3518 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MKNK2 Tchem MAP kinase-interacting serine/threonine-protein kinase 1/2 (155 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mknk1 MAP kinase-interacting serine/threonine-protein kinase 1 (6 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mknk2 MAP kinase-interacting serine/threonine-protein kinase 2 (8 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
3T3-L1 (3664 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mapk1 Mitogen-activated protein kinase 1 and 3 (ERK2 and ERK1) (70 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 471.60Molecular Weight (Monoisotopic): 471.2104AlogP: 4.89#Rotatable Bonds: 9
Polar Surface Area: 79.38Molecular Species: BASEHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.25CX LogP: 4.29CX LogD: 2.44
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.43Np Likeness Score: -2.23

References

1. Jin X, Merrett J, Tong S, Flower B, Xie J, Yu R, Tian S, Gao L, Zhao J, Wang X, Jiang T, Proud CG..  (2019)  Design, synthesis and activity of Mnk1 and Mnk2 selective inhibitors containing thieno[2,3-d]pyrimidine scaffold.,  162  [PMID:30496989] [10.1016/j.ejmech.2018.10.070]

Source